Health Canada is advising Canadians not to use the unauthorized smoking cessation product Resolve™, because of the potential health risk to consumers.

The product contains an unacceptable amount of an ingredient labelled as "CESTEMENOL-350." Consuming excessive amounts of this ingredient might result in damage to the kidney, liver or red blood cells.

Atherosclerotic peripheral arterial disease is associated with an increased risk of myocardial infarction, stroke, and death from cardiovascular causes. Antiplatelet drugs reduce this risk, but the role of oral anticoagulant agents in the prevention of cardiovascular complications in patients with peripheral arterial disease is unclear.

The U.S. Food and Drug Administration is warning consumers in USA not to buy or eat three red yeast rice products promoted and sold on Web sites. The products may contain an unauthorized drug that could be harmful to health. The products are promoted as dietary supplements for treating high cholesterol.

The Medicines and Healthcare products Regulatory Agency (MHRA), the British equivalent of the Saudi Food and Drug Authority (SFDA), announced that reports have been received of serious adverse drug reactions, including deaths, associated with the use of botulinum toxin products. Botox is the only brand name product registered by the Ministry of Health in Saudi Arabia.

The American Food and Drug Administration (FDA), the U.S. equivalent to the Saudi Food & Drug Authority(SFDA), that the manufacturers of the drugs rosiglitazone (Avandia) and pioglitazone (Actos) will revise the prescribing information for these drugs to include stronger warnings about the risk of congestive heart failure when these drug are used to treat type-2 diabetes.

The U.S. equivalent of the Saudi Food and Drug Authority (SFDA) announced important new information about serious, potentially life-threatening adverse drug effects in nursing infants whose mothers are taking the common painkiller and cough suppressant codeine. A list of some codeine containing products available in The Kingdom accompanies this alert.

Consents allowing the supply of 200mg and 400mg tablets of the COX-2 anti-inflammatory medicine Prexige have been revoked in New Zealand by the Medicines and Medical Devices Safety Authority, Medsafe.

Novartis, the pharmaceutical company sponsoring the medicine, is issuing a recall notice to suppliers of the tablets today.

Health Canada is reminding Canadians about the potential dangers of buying prescription drugs online, following the July 4th release of the British Columbia Coroner’s report on the death of a woman which was attributed to prescription drugs purchased online.

September 15, 2007, the US Food and drug Administration, the American's equivalent to the Saudi Food and Drug Authority (SFDA), announced important safety information regarding Normal Saline Flush Syringes